Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | LHCGR |
| Gene Name: | LHCGR |
| Protein Full Name: | Lutropin-choriogonadotropic hormone receptor |
| Alias: | LCGR; LGR2; LH/CG-R; LHCGR; LHRHR; LSHR; LSH-R; Luteinizing hormone receptor; Luteinizing hormone/choriogonadotropin receptor; Lutropin-choriogonadotropic hormone receptor |
| Mass (Da): | 78616 |
| Number AA: | 699 |
| UniProt ID: | P22888 |
| Locus ID: | 3973 |
| COSMIC ID: | LHCGR |
| Gene location on chromosome: | 2p21 |
| Cancer protein type: | OP |
| Effect of cancer mutation on protein: | GAIN |
| Effect of active protein on cancer: | PROMOTES |
| Number of cancer specimens: | 20122 |
| Percent of cancer specimens with mutations: | 1.14 |
| Normal role description: | LHCGR is a receptor for lutenizing hormone and choriogonadotropin. It regulates gonadal maturation, follicular development, formation of preovulatory follicles and corpora lutea, steroidogenesis and gametogenesis. Mutations lead dysregulation of signal pathways and oncogenesis of leydig cells. |